News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
614,986 Results
Type
Article (49144)
Company Profile (144)
Press Release (565698)
Section
Business (169840)
Career Advice (2578)
Deals (30687)
Drug Delivery (111)
Drug Development (76617)
Employer Resources (158)
FDA (15182)
Job Trends (13693)
News (299779)
Policy (30368)
Tag
2024 BioCapital Digital (3)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (5)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (6)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (8)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (3)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (5)
2025 Lone Star Bio Digital (1)
2026 BioCapital Elite (1)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
Academia (2739)
Academic (1)
Accelerated approval (4)
Adcomms (26)
Allergies (81)
Alliances (44091)
ALS (87)
Alzheimer's disease (1424)
Antibody-drug conjugate (ADC) (126)
Approvals (15167)
Artificial intelligence (259)
Autoimmune disease (18)
Automation (14)
Bankruptcy (329)
Best Places to Work (10852)
BIOSECURE Act (18)
Biosimilars (90)
Biotechnology (98)
Bladder cancer (60)
Brain cancer (27)
Breast cancer (248)
Cancer (2006)
Cardiovascular disease (182)
Career advice (2171)
Career pathing (33)
CAR-T (140)
Cell therapy (393)
Cervical cancer (18)
Clinical research (62016)
Collaboration (725)
Compensation (276)
Complete response letters (26)
COVID-19 (2602)
CRISPR (38)
C-suite (225)
Cystic fibrosis (92)
Data (1944)
Decentralized trials (2)
Denatured (41)
Depression (47)
Diabetes (247)
Diagnostics (6725)
Digital health (16)
Diversity (8)
Diversity, equity & inclusion (39)
Drug discovery (111)
Drug pricing (103)
Drug shortages (27)
Duchenne muscular dystrophy (90)
Earnings (60870)
Editorial (34)
Employer branding (21)
Employer resources (141)
Events (88228)
Executive appointments (668)
FDA (16262)
Featured Employer (32)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (678)
Gene editing (96)
Generative AI (23)
Gene therapy (294)
GLP-1 (739)
Government (4492)
Grass and pollen (5)
Guidances (46)
Healthcare (17602)
Huntington's disease (23)
IgA nephropathy (26)
Immunology and inflammation (120)
Indications (27)
Infectious disease (2741)
Inflammatory bowel disease (131)
Inflation Reduction Act (11)
Influenza (49)
Intellectual property (85)
Interviews (541)
IPO (13702)
IRA (46)
Job creations (3254)
Job search strategy (1791)
Kidney cancer (10)
Labor market (23)
Layoffs (454)
Leadership (20)
Legal (6828)
Liver cancer (71)
Lung cancer (302)
Lymphoma (132)
Machine learning (4)
Management (55)
Manufacturing (255)
MASH (68)
Medical device (11908)
Medtech (11912)
Mergers & acquisitions (17441)
Metabolic disorders (660)
Multiple sclerosis (76)
NASH (23)
Neurodegenerative disease (96)
Neuropsychiatric disorders (30)
Neuroscience (1940)
NextGen: Class of 2025 (6094)
Non-profit (4338)
Northern California (2133)
Now hiring (33)
Obesity (355)
Opinion (222)
Ovarian cancer (70)
Pain (79)
Pancreatic cancer (76)
Parkinson's disease (139)
Partnered (20)
Patents (195)
Patient recruitment (94)
Peanut (47)
People (54349)
Pharmaceutical (37)
Pharmacy benefit managers (15)
Phase I (19097)
Phase II (27208)
Phase III (20717)
Pipeline (1054)
Podcasts (115)
Policy (123)
Postmarket research (2578)
Preclinical (7982)
Press Release (62)
Prostate cancer (95)
Psychedelics (38)
Radiopharmaceuticals (244)
Rare diseases (367)
Real estate (5397)
Recruiting (63)
Regulatory (21031)
Reports (29)
Research institute (2376)
Resumes & cover letters (370)
Rett syndrome (4)
RNA editing (3)
RSV (39)
Schizophrenia (72)
Series A (124)
Series B (77)
Service/supplier (6)
Sickle cell disease (52)
Southern California (1888)
Special edition (11)
Spinal muscular atrophy (152)
Sponsored (30)
Startups (3228)
State (2)
Stomach cancer (15)
Supply chain (55)
Tariffs (11)
The Weekly (72)
United States (19238)
Vaccines (641)
Venture capitalists (34)
Webinars (12)
Weight loss (251)
Women's health (36)
Worklife (17)
Date
Today (102)
Last 7 days (689)
Last 30 days (2535)
Last 365 days (31280)
2025 (7723)
2024 (32840)
2023 (37013)
2022 (47654)
2021 (51345)
2020 (50258)
2019 (43577)
2018 (33030)
2017 (29943)
2016 (29143)
2015 (33884)
2014 (26303)
2013 (22206)
2012 (23612)
2011 (24625)
2010 (22406)
Location
Africa (802)
Alabama (47)
Alaska (4)
Arizona (183)
Arkansas (13)
Asia (37124)
Australia (7382)
California (4874)
Canada (1758)
China (449)
Colorado (222)
Connecticut (232)
Delaware (120)
Europe (84092)
Florida (765)
Georgia (174)
Idaho (54)
Illinois (476)
India (22)
Indiana (269)
Iowa (7)
Japan (138)
Kansas (88)
Kentucky (22)
Louisiana (8)
Maine (59)
Maryland (774)
Massachusetts (3820)
Michigan (201)
Minnesota (321)
Mississippi (1)
Missouri (76)
Montana (27)
Nebraska (24)
Nevada (54)
New Hampshire (65)
New Jersey (1459)
New Mexico (28)
New York (1472)
North Carolina (852)
North Dakota (6)
Northern California (2133)
Ohio (184)
Oklahoma (11)
Oregon (32)
Pennsylvania (1096)
Puerto Rico (10)
Rhode Island (26)
South America (1144)
South Carolina (15)
South Dakota (1)
Southern California (1888)
Tennessee (83)
Texas (754)
Utah (164)
Virginia (126)
Washington D.C. (54)
Washington State (472)
West Virginia (3)
Wisconsin (51)
614,986 Results for "boston heart diagnostics formerly known as boston heart lab".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Volta Medical Announces Presentations at Heart Rhythm Society 2024 in Boston, MA, USA
Volta Medical today announced presentations to be made at the Heart Rhythm Society 2024 meeting in Boston, May 16 to 19. In-person attendance and live online participation in a hybrid format will be available.
April 18, 2024
·
4 min read
Press Releases
Boston Scientific announces agreement to acquire SoniVie Ltd.
March 4, 2025
·
7 min read
Press Releases
Cardiol Therapeutics Announces Publication of Research in the Journal of the American College of Cardiology: Basic to Translational Science That Supports Development of Its Proprietary Subcutaneous Drug Candidate, CRD-38, for the Treatment of Heart Failure
Data demonstrates improvement in cardiac function and reductions in cardiac hypertrophy, remodeling, inflammation, and cell death - key underlying mechanisms in heart failure
February 20, 2025
·
7 min read
BioMidwest
Stereotaxis Invited by Africa Heart Rhythm Association to Present its Innovative Robotic Solution to Expand High-Quality Therapy in Underserved Regions of Africa
Stereotaxis announced that it has been invited to present at HRS Africa Summit 2024, scheduled to take place during Heart Rhythm Society Scientific Sessions this week in Boston, Massachusetts.
May 15, 2024
·
5 min read
Lone Star Bio
Integer to Showcase Strategic Investments to Support Customers’ Growth and Innovation at Heart Rhythm 2024
Integer Holdings Corporation will join medtech industry leaders around the world in exhibiting at Heart Rhythm 2024, a Heart Rhythm Society educational event and exhibition in Boston from May 16 – 19, 2024.
May 7, 2024
·
2 min read
MASH
Boston Pharma Carves Out Monthly Treatment Niche in MASH With Strong Phase II Data
Boston Pharma’s once-monthly injection efimosfermin alfa offers a convenient dosing option for MASH patients while also achieving promising rates of fibrosis and MASH improvement, according to a Phase II readout.
November 18, 2024
·
2 min read
·
Tristan Manalac
Daxor Corporation to Exhibit at the Technology and Heart Failure Therapeutics Conference
Daxor Corporation today announces it will be exhibiting at the Technology and Heart Failure Therapeutics Conference (THT), which brings together the world’s leading experts in heart failure innovations at the Westin Boston Seaport in Boston, Massachusetts March 4-6, 2024.
February 26, 2024
·
3 min read
Press Releases
Boston Scientific announces conference call discussing first quarter 2025 results
April 1, 2025
·
1 min read
Press Releases
Boston Scientific announces pricing of €1.5 billion of senior notes
February 24, 2025
·
5 min read
Bio NC
Milestone® Pharmaceuticals Announces Data Presentations on Etripamil at Heart Rhythm 2024, 2024 Stanford BioDesign Arrhythmia Technologies Retreat, and ISPOR 2024
Milestone® Pharmaceuticals Inc. announced upcoming data presentations on etripamil at ISPOR 2024 being held in Atlanta, GA on May 5-8, 2024, the 2024 Stanford BioDesign Arrhythmia Technologies Retreat in Boston, MA, on May 15, 2024, and the Annual meeting of the Heart Rhythm Society, Heart Rhythm 2024, in Boston, MA on May 16-19, 2024.
May 2, 2024
·
1 min read
1 of 61,499
Next
